期刊文献+

大面积脑梗死60例临床分析 被引量:1

下载PDF
导出
摘要 目的分析大面积脑梗死的病因、临床特点、治疗方法及预防。方法回顾性分析我科2010-12—2011-12收治的60例大面积脑梗死患者的临床表现、头颅MRI检查结果及治疗。结果心源性脑栓塞占全部脑梗死的12.1%,房颤是心源性脑栓塞的最重要的危险因素[1],发病后治疗困难,病死率、致残率较高,预后差。结论心房颤动是导致大面积脑梗死的主要因素,应积极对心房纤颤进行抗凝治疗,防止脑栓塞的发生。
作者 谢荣宇
出处 《中国实用神经疾病杂志》 2014年第1期66-67,共2页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献10

  • 1赵秀敏.房颤致脑栓塞60例临床分析[J].中国实用神经疾病杂志,2006,9(4):100-101. 被引量:26
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 3沈谨 钱贻简 陶恒乐等.老年人心房颤动的原因(26例临床病理对照分析).中华老年医学杂志,2004,23(8):136-137.
  • 4Li-Saw-Hee FL,Blann AD, Lip GY. A cross-sectional and di- urnal study of thrombogenesis among patients with chronic atril fibrillation[J]. J Am Coll Cardiol, 2000, 35(7).. 1 926-1 931.
  • 5李馨,高淑杰,李天明.心源性脑栓塞50例临床分析[J].中国实用医药,2008,3(29):79-80. 被引量:10
  • 6Segal JB ,Me Namara RL , Miller MR , et al . Prevention of thromboembolismin atrial fibrillation. Ameta-analysis of trials of anticoagulant and antiplatelet drugs[J] . J Gen Intern Med, 2000,15(1) 56-57.
  • 7左惠娟,苏江莲,曾辉,袁宝弘,姚崇华.北京市非瓣膜心房颤动病人日常抗血栓治疗现况分析[J].中华医学杂志,2007,87(33):2328-2331. 被引量:18
  • 8SPAF HI Writing Committee for the Stroke Prevention in Atrial FibrillationInvestigatiors. Patients with nonvalvular atrial fi- brillation at low risk of stroke during treatment with aspirin ; Stroke prevention in Atrial Fibrillation 1]I Study[J] . JAMA , 1998 ,279(16):1 273 1 277.
  • 9Khoo CW, Lip GY. Insights from the dabigatran versus warfa- rin in patientswith atrial fibrillation (RE-LY) trial [J]. Expert OpinPharm acother, 2010,11(4) : 685-687.
  • 10Haas S. New oral Xa and IIa inhibitors: updates on clinical trial results[ J]. J Throm b Throm bolysis, 2008,25(1) 52 60.

二级参考文献15

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2蒋海杰,朱宁,王常青.大连市房颤住院患者诊治状况调查分析[J].大连医科大学学报,2006,28(1):54-56. 被引量:5
  • 3马长生.心房颤动导管消融适应证当前的争论[J].中华医学杂志,2006,86(16):1081-1082. 被引量:2
  • 4胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 5[1]黄友歧主编.神经病学[M].北京:人民教育出版社,1989.153~155
  • 6Atrial fibrillation investigator: risk factors for stroke and efficacy of antithrombotic therapy an atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Aach intern Med, 1994, 154 : 1449-1457.
  • 7Stenestrand U, lindback J, Wallentin L, et aL Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influende long-term outcome. Circulation, 2005, 112 : 3225 -3231.
  • 8Nilsson GH, Bjorhoh I, Krakan I. Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden--a retrospective of incidence and quality in registered population. Family Practice, 2004,6:612-616.
  • 9Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation : the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126 ( 3 Suppl) :429S-456S.
  • 10Copper NS, Sutton A J, Lu K, et al. Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Arch Intern Med, 2006,12 : 1269-1275.

共引文献33063

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部